{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:57:29Z","timestamp":1791302249362,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1093\/toxsci\/kft113","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T22:16:34Z","timestamp":1369088194000},"page":"412-426","source":"Crossref","is-referenced-by-count":218,"title":["Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes to Functional Preclinical Safety Assays"],"prefix":"10.1093","volume":"134","author":[{"given":"Kate","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Aylott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Louttit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"key\n\t\t\t\t20170508161706_CIT0001","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1254\/jphs.QT-A4","article-title":"QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation","volume":"99","year":"(2005)","journal-title":"J. Pharmacol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0002","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/clpt.2011.9","article-title":"Opportunities for use of human iPS cells in predictive toxicology","volume":"89","year":"(2011)","journal-title":"Clin. Pharmacol. Ther"},{"key":"key\n\t\t\t\t20170508161706_CIT0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-8703(83)90271-5","article-title":"Concurrent use of quinidine and disopyramide: Evaluation of serum concentrations and electrocardiographic effects","volume":"105","year":"(1983)","journal-title":"Am. Heart J"},{"key":"key\n\t\t\t\t20170508161706_CIT0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1056-8719(03)00009-1","article-title":"A method for QT correction based on beat-to-beat analysis of the QT\/RR interval relationship in conscious telemetred beagle dogs","volume":"48","year":"(2002)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00005344-199107000-00008","article-title":"Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: Differential actions of class Ib and Ic agents","volume":"18","year":"1991","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0006","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.1991.tb01488.x","article-title":"Differential effects on action potential duration of class IA, B and C antiarrhythmic drugs: Modulation by stimulation rate and extracellular K+ concentration","volume":"18","year":"1991","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-199921001-00004","article-title":"Preclinical in vitro cardiac electrophysiology: A method of predicting arrhythmogenic potential of antihistamines in humans?","volume":"21","year":"(1999)","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20170508161706_CIT0008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-9149(85)90306-6","article-title":"Intravenous quinidine: Relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia","volume":"55","year":"(1985)","journal-title":"Am. J. Cardiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vascn.2012.03.004","article-title":"How do the top 12 pharmaceutical companies operate safety pharmacology?","volume":"66","year":"(2012)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0010","first-page":"18","volume-title":"Pharmacology review of NDA 21\u2013879","author":"FDA","year":"(2010)"},{"key":"key\n\t\t\t\t20170508161706_CIT0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jelectrocard.2003.09.054","article-title":"Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes","volume":"36","year":"(2003)","journal-title":"J. Electrocardiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/toxsci\/kfr158","article-title":"Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes","volume":"123","year":"2011","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0013","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000329966","article-title":"The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts","volume":"27","year":"2011","journal-title":"Cell. Physiol. Biochem"},{"key":"key\n\t\t\t\t20170508161706_CIT0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000074542","article-title":"Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures","volume":"13","year":"(2003)","journal-title":"Cell. Physiol. Biochem"},{"key":"key\n\t\t\t\t20170508161706_CIT0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vascn.2006.05.001","article-title":"ILSI-HESI cardiovascular safety subcommittee initiative: Evaluation of three non-clinical models of QT prolongation","volume":"54","year":"(2006)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0016","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","year":"(2011)","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0017","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.vascn.2010.12.004","article-title":"Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical","volume":"63","year":"(2011)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0018","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1476-5381.2011.01775.x","article-title":"Field and action potential recordings in heart slices: Correlation with established in vitro and in vivo models","volume":"166","year":"(2012)","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0019","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FJC.0b013e3182135e91","article-title":"Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine","volume":"57","year":"(2011)","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.109.205740","article-title":"On the road to iPS cell cardiovascular applications","volume":"105","year":"(2009)","journal-title":"Circ. Res"},{"key":"key\n\t\t\t\t20170508161706_CIT0021","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","year":"(2004)","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20170508161706_CIT0022","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14740338.2012.639358","article-title":"Cardiac safety pharmacology: From human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models","volume":"11","year":"(2012)","journal-title":"Expert Opin. Drug Saf"},{"key":"key\n\t\t\t\t20170508161706_CIT0023","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0706894","article-title":"A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes","volume":"149","year":"(2006)","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0024","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.hrthm.2006.04.021","article-title":"Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias","volume":"3","year":"(2006)","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20170508161706_CIT0025","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.hrthm.2012.06.030","article-title":"Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation","volume":"9","year":"(2012)","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20170508161706_CIT0026","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1476-5381.2012.01880.x","article-title":"Does terfenadine-induced ventricular tachycardia\/fibrillation directly relate to its QT prolongation and Torsades de Pointes?","volume":"166","year":"(2012)","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0027","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.CIR.85.3.1175","article-title":"Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current","volume":"85","year":"(1992)","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170508161706_CIT0028","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents","volume":"301","year":"(2011)","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12576-009-0029-7","article-title":"Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its beta1 subunit","volume":"59","year":"(2009)","journal-title":"J. Physiol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0030","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.98.23.2545","article-title":"Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes","volume":"98","year":"(1998)","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170508161706_CIT0031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cardiores.2005.08.015","article-title":"A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes","volume":"69","year":"(2006)","journal-title":"Cardiovasc. Res"},{"key":"key\n\t\t\t\t20170508161706_CIT0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1248\/bpb.27.131","article-title":"Lack of action potential-prolonging effect of terfenadine on rabbit myocardial tissue preparations","volume":"27","year":"(2004)","journal-title":"Biol. Pharm. Bull"},{"key":"key\n\t\t\t\t20170508161706_CIT0033","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","year":"(2011)","journal-title":"Cardiovasc. Res"},{"key":"key\n\t\t\t\t20170508161706_CIT0034","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1254\/jphs.QT-C9","article-title":"QT PRODACT: Sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation","volume":"99","year":"(2005)","journal-title":"J. Pharmacol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","year":"(2012)","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20170508161706_CIT0036","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1254\/jphs.QT-C12","article-title":"QT PRODACT: Comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans","volume":"99","year":"(2005)","journal-title":"J. Pharmacol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0037","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","article-title":"The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes","volume":"61","year":"(2010)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0038","article-title":"Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay","year":"(2013)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0039","doi-asserted-by":"crossref","first-page":"H1278","DOI":"10.1152\/ajpheart.00777.2005","article-title":"Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr)","volume":"290","year":"(2006)","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0040","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.biomaterials.2012.11.055","article-title":"The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells","volume":"34","year":"(2013)","journal-title":"Biomaterials"},{"key":"key\n\t\t\t\t20170508161706_CIT0041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","year":"(2003)","journal-title":"Cardiovasc. Res"},{"key":"key\n\t\t\t\t20170508161706_CIT0042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1472-8206.2002.00098.x","article-title":"Safety pharmacology\u2013a progressive approach","volume":"16","year":"(2002)","journal-title":"Fundam. Clin. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0043","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1681.1998.tb02360.x","article-title":"Propofol block of cardiac sodium currents in rat isolated myocardial cells is increased at depolarized resting potentials","volume":"25","year":"(1998)","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"key\n\t\t\t\t20170508161706_CIT0044","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1254\/jphs.QT-A3","article-title":"QT PRODACT: In vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals","volume":"99","year":"(2005)","journal-title":"J. Pharmacol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vascn.2007.04.005","article-title":"Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization","volume":"56","year":"(2007)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0046","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.QT-A2","article-title":"QT PRODACT: In vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals","volume":"99","year":"(2005)","journal-title":"J. Pharmacol. Sci"},{"key":"key\n\t\t\t\t20170508161706_CIT0047","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vascn.2009.05.011","article-title":"A framework to assess the translation of safety pharmacology data to humans","volume":"60","year":"(2009)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0048","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vascn.2008.05.007","article-title":"Safety and secondary pharmacology: successes, threats, challenges and opportunities","volume":"58","year":"(2008)","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20170508161706_CIT0049","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2002.00099.x","article-title":"The application of in vitro methods to safety pharmacology","volume":"16","year":"(2002)","journal-title":"Fundam. Clin. Pharmacol"},{"key":"key\n\t\t\t\t20170508161706_CIT0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCRESAHA.112.265173","article-title":"Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic","volume":"111","year":"(2012)","journal-title":"Circ. Res"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/134\/2\/412\/16685593\/kft113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:14:22Z","timestamp":1563048862000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kft113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,5,20]]},"published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kft113","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]}}}